Mobile

Clinical study for the evaluation of the safety and efficacy of masitinib in patients suffering from parkinson's disease Klinická štúdia pre hodnotenie bezpečnosti a účinnosti masitinibu u pacie...

Update Il y a 4 ans
Reference: EUCTR2010-024424-26

Clinical study for the evaluation of the safety and efficacy of masitinib in patients suffering from parkinson's disease Klinická štúdia pre hodnotenie bezpečnosti a účinnosti masitinibu u pacientov trpiacich Parkinsonovou chorobou

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The objective is to compare the efficacy and safety of masitinib in cognitively impaired but non-demented Parkinson's disease patients Primary endpoint • ADCS-ADL score at week 48 CIELE: Cieľom je porovnať účinnosť a bezpečnosť masitinibu u pacientov s Parkinsonovou chorobou so zníženou kognitívnou funkciou, ale bez demencie. Primárne ciele: - ADCS-ADL skóre v týždni 48

Inclusion criteria

  • Parkinson's disease,Pariksonova nemoc

Links